Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PhRMA Sees Canadian Currency Devaluation As Grounds For Trade Action

Executive Summary

PhRMA believes that the inability of pharmaceutical manufacturers to raise prices in Canada to reflect the devaluation of the Canadian dollar is "contrary to the spirit" of the North American Free Trade Agreement.

You may also be interested in...

Drug Prices Not Responsible For Premium Hikes - HIAA, PhRMA Studies

Only a small part of recent increases in health insurance premiums can be attributed to the cost of prescription drugs, according to two reports released the week of April 10 by the pharmaceutical and health insurance industries.

Senior Coverage Increases Per Capita Drug Spend By 66%, HHS Report Finds

Average per capita spending on drugs for Medicare eligibles with drug insurance was 66% higher in 1996 than spending on pharmaceuticals for non-covered elderly, according to an analysis of drug spending released by the Clinton Administration on April 10.

Maine Rx Pricing Board Would Use FSS, Canadian Prices As Benchmark

A Maine drug pricing board would use federal supply schedule drug prices and Canadian drug prices to set maximum prescription drug prices in the state under a proposed bill.

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts